superDimension, a Minneapolis, MN-based company that develops minimally invasive interventional pulmonology devices, has raised $24.8m in debt and equity financing in two separate transactions.
The $24.8m capital raise included a $9.8m equity round of financing and a new $15m credit facility with Oxford Finance Corporation.
All of the company’s existing investors participated in the equity financing, including OrbiMed Advisors, Oxford Biosciences Partners, Pitango Venture Capital, Medica Venture Partners, Dan Sullivan Investments, and one undisclosed institutional investor.
This additional financing will allow superDimension to further strengthen its commercial infrastructure and sales and marketing team.
The company’s Electromagnetic Navigation Bronchoscopy (ENB) is a minimally invasive procedure, where a catheter is inserted through the throat and uses Global Positioning System (GPS)- like technology to biopsy lung lesions and lymph nodes all in one outpatient procedure.